Johns Hopkins Medicine
Media Relations and Public Affairs
Media Contact: Eric Vohr
April 20, 2007
MOOD DISORDERS SYMPOSIUM WILL DISCUSS NEW FINDINGS IN RESEARCH AND TREATMENT OF BIPOLAR DISORDERS AND RECURRENT DEPRESSION
-- Co-authors Frederick K. Goodwin, M.D., and Kay Redfield Jamison, Ph.D., will discuss the new edition of “Manic Depressive Illness: Bipolar Disorders and Recurrent Depression.”
The Johns Hopkins University School of Medicine will hold its 21st annual Mood Disorders Symposium titled “Bipolar Revisited: Where We’ve Been, Where We’re Going,” at the Johns Hopkins School of Medicine, April 24, to draw attention to new findings in basic and clinical research on depression and bipolar disorder.
The symposium, to be held in the Thomas B. Turner Building, 720 Rutland Ave., at the Johns Hopkins medical campus, will feature the just-out second edition of “Manic Depressive Illness.”
This revised edition, co-authored by former National Institute of Mental Health Director Frederick K. Goodwin, M.D. -- now at the Department of Psychiatry at George Washington University -- and Kay Redfield Jamison, Ph.D., of the Department of Psychiatry at Johns Hopkins, describes a wealth of new discovery about a disease that plagues an estimated six million people in the United States alone.
“The 17 years since the publication of the first edition of this text have been the most explosively productive years in the history of medical science,” says Goodwin.
“In every field relevant to our understanding of manic-depressive illness -- genetics, neurobiology, psychology and neuropsychology, neuroanatomy, diagnosis and treatment -- we have gained a staggering amount of knowledge.”
Jamison and Goodwin drew from the vastly expanded scientific knowledge by enlisting the assistance of a distinguished group of collaborators. Three of the collaborators will join the symposium -- James Potash, M.D., M.P.H., and Frank Mondimore, M.D., of the Department of Psychiatry at Johns Hopkins, and Harold Sackeim, Ph.D., of the Department of Psychiatry at Columbia University. In addition, United States Representative Sue Myrick of North Carolina, who has had personal experience with bi-polar disease in her family, will give families and patients a unique perspective on this illness.
Depression and bipolar disorder are implicated in the overwhelming majority of suicides, killing more than 30,000 people in the United States each year. Suicide is the third leading cause of death in young people. In addition, the World Health Organization estimates that by 2020, depression will be the second leading cause of “lost years of healthy life” worldwide. The worldwide economic cost of depression is estimated at $80 billion a year.
Intended for psychiatrists, social workers, psychologists and counselors, the event is also open to patients, family members and anyone who has an interest in learning more about bipolar disorders and recurrent depression. Registrants will participate in open discussions with researchers and clinicians from Johns Hopkins and other institutions.
The symposium is presented by the Department of Psychiatry and Behavioral Sciences, the Johns Hopkins Mood Disorders Center and Johns Hopkins Continuing Medical Education.